FIELD: medicine.
SUBSTANCE: for prevention and treatment of retinopathy in dismature infants with age of gestation from 29 weeks onto both child's eyes immediately after birth by lightproof bandage is applied. In addition, rectally daily during 3-4 months plasma is introduced, obtained from parent's blood, who was in conditions of darkness with opened eyes during 30-45 minutes.
EFFECT: invention ensures formation of morphologically and functionally full-fledged retina by removal of damaging light influence on retina and supply of child's organism with energetic and plastic material, obtained from parent's blood plasma.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMPROVING VISION FUNCTION IN PATIENTS SUFFERING FROM VASCULAR AND DYSTROPHIC EYE FUNDUS DISEASES | 2004 |
|
RU2291698C2 |
| METHOD FOR IMPROVING ACUITY IN PATIENTS WITH VASCULAR AND DYSTROPHIC RETINAL DISEASES | 2003 |
|
RU2258490C1 |
| METHOD FOR PREDICTION OF LASER COAGULATION NECESSITY FOR PREMATURE RETINOPATHY | 2016 |
|
RU2630614C1 |
| METHOD FOR TREATING HEMORRHAGE INTO EYE INTERNAL MEDIA AND SCLERA AND RETINA | 1996 |
|
RU2119316C1 |
| PREDICTION METHOD OF PREMATURE RETINOPATHY LASER COAGULATION USE | 2016 |
|
RU2621307C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF POSTERIOR AGGRESSIVE RETINOPATHY IN PREMATURE INFANTS | 2010 |
|
RU2441593C1 |
| METHOD FOR PREDICTION OF RETINOPATHY OF PREMATURITY | 2015 |
|
RU2582049C1 |
| METHOD FOR REDUCING ENERGY OF LASER EXPOSURE ON THE PATIENT'S RETINA WITH ACTIVE RETINOPATHY OF PREMATURE NEWBORNS | 2019 |
|
RU2704233C1 |
| METHOD FOR PREPARING BLOOD WITH INCREASED CONTENT OF NUCLEOSIDES AND NUCLEOTIDES | 2004 |
|
RU2290938C2 |
| METHOD FOR PREDICTING AN UNFAVORABLE COURSE OF RETINOPATHY IN PREMATURE INFANTS | 2021 |
|
RU2761268C1 |
